Milestone Pharmaceuticals (MIST) Short Interest Ratio & Short Volume → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free MIST Stock Alerts $1.73 +0.01 (+0.58%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Milestone Pharmaceuticals Short Interest DataCurrent Short Volume430,000 sharesPrevious Short Volume431,400 sharesChange Vs. Previous Month-0.32%Dollar Volume Sold Short$709,500.00Short Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Outstanding Shares53,150,000 sharesPercentage of Shares Shorted0.81%Today's Trading Volume49,481 sharesAverage Trading Volume284,232 sharesToday's Volume Vs. Average17% Short Selling Milestone Pharmaceuticals ? Sign up to receive the latest short interest report for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMIST Short Interest Over TimeMIST Days to Cover Over TimeMIST Percentage of Float Shorted Over Time Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. Milestone Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024430,000 shares $709,500.00 -0.3%N/A1.3 $1.65 4/15/2024431,400 shares $757,107.00 -22.9%N/A1.4 $1.76 3/31/2024559,500 shares $1.00 million +16.5%N/A1.6 $1.79 3/15/2024480,100 shares $696,145.00 +6.4%N/A1.1 $1.45 2/29/2024451,300 shares $758,184.00 +19.8%N/A1.1 $1.68 2/15/2024376,700 shares $602,720.00 -7.1%N/A1.2 $1.60 Get the Latest News and Ratings for MIST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024405,300 shares $648,480.00 -0.1%N/A1.4 $1.60 1/15/2024405,600 shares $628,680.00 -14.9%N/A1.5 $1.55 12/31/2023476,800 shares $796,256.00 +27.7%N/A2 $1.67 12/15/2023373,300 shares $974,313.00 -4.2%N/A1.9 $2.61 11/30/2023389,500 shares $1.30 million +1.5%N/A3.2 $3.34 11/15/2023383,900 shares $871,453.00 +12.3%N/A4.1 $2.27 10/31/2023342,000 shares $875,520.00 -6.1%N/A4.6 $2.56 10/15/2023364,300 shares $1.06 million -9.3%N/A4 $2.90 9/30/2023401,600 shares $1.24 million -16.8%N/A4 $3.10 9/15/2023482,800 shares $1.52 million -6.3%N/A4 $3.15 8/31/2023515,300 shares $1.38 million -45.4%N/A4 $2.68 8/15/2023943,800 shares $3.02 million +4.4%N/A7.3 $3.20 7/31/2023904,400 shares $2.92 million -1.8%N/A7 $3.23 7/15/2023921,200 shares $3.24 million +5.3%N/A8.6 $3.52 6/30/2023875,200 shares $2.49 million -14.2%N/A8.2 $2.85 6/15/20231,020,000 shares $3.81 million No ChangeN/A9.3 $3.74 5/31/20231,020,000 shares $4.02 million No ChangeN/A9.7 $3.94 5/15/20231,020,000 shares $4.29 million -2.9%N/A9 $4.21 4/30/20231,050,000 shares $3.81 million +4.0%N/A8.6 $3.63 4/15/20231,010,000 shares $3.63 million +5.2%3.4%6.7 $3.59 3/31/2023960,000 shares $3.78 million -0.6%N/A5.7 $3.94 3/15/2023966,100 shares $3.41 million +5.2%N/A6 $3.53 2/28/2023918,200 shares $2.90 million -0.2%N/A4.2 $3.16 2/15/2023919,700 shares $3.26 million +2.7%N/A4.1 $3.54 1/31/2023895,800 shares $3.28 million -0.9%3.1%3 $3.66 1/15/2023903,800 shares $3.55 million -8.9%3.1%2.1 $3.93 12/30/2022992,000 shares $3.93 million +1.3%3.4%1.5 $3.96 12/15/2022979,300 shares $3.72 million +13.4%3.4%1.5 $3.80 11/30/2022863,300 shares $4.24 million -2.1%3.0%1.3 $4.91 11/15/2022881,900 shares $3.86 million +0.4%3.1%1.3 $4.38 10/31/2022878,300 shares $4.41 million +9.1%4.0%1.3 $5.02 10/15/2022805,200 shares $6.84 million -4.7%4.3%1.4 $8.49 9/30/2022845,000 shares $7.77 million +2.1%4.5%3 $9.19 9/15/2022827,600 shares $7.57 million +9.7%4.5%3.6 $9.15The most important AI company you've never heard of (Ad)Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth MIST Short Interest - Frequently Asked Questions What is Milestone Pharmaceuticals' current short interest? Short interest is the volume of Milestone Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 430,000 shares of MIST short. Learn More on Milestone Pharmaceuticals' current short interest. What is a good short interest ratio for Milestone Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MIST shares currently have a short interest ratio of 1.0. Learn More on Milestone Pharmaceuticals's short interest ratio. Is Milestone Pharmaceuticals' short interest increasing or decreasing? Milestone Pharmaceuticals saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 430,000 shares, a decline of 0.3% from the previous total of 431,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Milestone Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Milestone Pharmaceuticals: Annovis Bio, Inc. (14.41%), ProPhase Labs, Inc. (1.88%), YS Biopharma Co., Ltd. (0.32%), Barinthus Biotherapeutics plc (0.05%), Chimerix, Inc. (1.71%), Eton Pharmaceuticals, Inc. (0.36%), LifeVantage Co. (0.78%), Oncolytics Biotech Inc. (1.14%), IO Biotech, Inc. (0.10%), Anixa Biosciences, Inc. (2.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Milestone Pharmaceuticals stock? Short selling MIST is an investing strategy that aims to generate trading profit from Milestone Pharmaceuticals as its price is falling. MIST shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Milestone Pharmaceuticals? A short squeeze for Milestone Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MIST, which in turn drives the price of the stock up even further. How often is Milestone Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MIST, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Annovis Bio Short Interest ProPhase Labs Short Interest YS Biopharma Short Interest Barinthus Biotherapeutics Short Interest Chimerix Short Interest Eton Pharmaceuticals Short Interest LifeVantage Short Interest Oncolytics Biotech Short Interest IO Biotech Short Interest Anixa Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MIST) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity